[go: up one dir, main page]

EE200300116A - Efektiivne meetod faktori Xa inhibiitori valmistamiseks - Google Patents

Efektiivne meetod faktori Xa inhibiitori valmistamiseks

Info

Publication number
EE200300116A
EE200300116A EEP200300116A EEP200300116A EE200300116A EE 200300116 A EE200300116 A EE 200300116A EE P200300116 A EEP200300116 A EE P200300116A EE P200300116 A EEP200300116 A EE P200300116A EE 200300116 A EE200300116 A EE 200300116A
Authority
EE
Estonia
Prior art keywords
inhibitor
factor
preparation
effective method
effective
Prior art date
Application number
EEP200300116A
Other languages
English (en)
Inventor
Li Hui-Yin
Anzalone Luigi
Jin Fuqiang
J. Meloni David
Sun Jung-Hui
A. Teleha Christopher
Cheng Zhou Jia
E. Smyser Thomas
Original Assignee
Bristol-Myers Squibb Pharma Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Pharma Company filed Critical Bristol-Myers Squibb Pharma Company
Publication of EE200300116A publication Critical patent/EE200300116A/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EEP200300116A 2000-09-22 2001-09-12 Efektiivne meetod faktori Xa inhibiitori valmistamiseks EE200300116A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23462200P 2000-09-22 2000-09-22
PCT/US2001/028406 WO2002024690A2 (en) 2000-09-22 2001-09-12 Efficient process for the preparation of a factor xa inhibitor

Publications (1)

Publication Number Publication Date
EE200300116A true EE200300116A (et) 2005-04-15

Family

ID=22882119

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300116A EE200300116A (et) 2000-09-22 2001-09-12 Efektiivne meetod faktori Xa inhibiitori valmistamiseks

Country Status (23)

Country Link
US (3) US6667332B2 (et)
EP (1) EP1366045A2 (et)
JP (1) JP2004529853A (et)
KR (1) KR20040043089A (et)
CN (1) CN1610679A (et)
AU (1) AU2001292612A1 (et)
BG (1) BG107813A (et)
BR (1) BR0114102A (et)
CA (1) CA2424576A1 (et)
CZ (1) CZ2003835A3 (et)
EE (1) EE200300116A (et)
HR (1) HRP20030316A2 (et)
HU (1) HUP0500133A2 (et)
IL (1) IL155043A0 (et)
IS (1) IS6754A (et)
MX (1) MXPA03002493A (et)
NO (1) NO20031308L (et)
PL (1) PL366027A1 (et)
RU (1) RU2003111464A (et)
SK (1) SK4892003A3 (et)
TW (1) TW593314B (et)
WO (1) WO2002024690A2 (et)
ZA (1) ZA200302971B (et)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339099B1 (en) * 1997-06-20 2002-01-15 Dupont Pharmaceuticals Company Guanidine mimics as factor Xa inhibitors
WO2002006218A2 (en) * 2000-07-18 2002-01-24 Bone Care International, Inc. STABILIZED 1α-HYDROXY VITAMIN D
TW200302225A (en) * 2001-12-04 2003-08-01 Bristol Myers Squibb Co Substituted amino methyl factor Xa inhibitors
US20040067995A1 (en) * 2002-10-02 2004-04-08 Wong Pancras C. Novel combination of a factor Xa inhibitor and clopidogrel
JP4435691B2 (ja) * 2002-11-06 2010-03-24 パナソニック株式会社 変位検出機能を備えたマイクロアクチュエータ、および当該マイクロアクチュエータを備えた可変形ミラー
US7429581B2 (en) * 2002-12-23 2008-09-30 Sanofi-Aventis Deutschland Gmbh Pyrazole-derivatives as factor Xa inhibitors
US20050059719A1 (en) * 2003-09-16 2005-03-17 Badawy Sherif Ibrahim Farag Solid dosage formulation containing a Factor Xa inhibitor and method
MY199131A (en) 2014-03-07 2023-10-17 Biocryst Pharm Inc Human plasma kallikrein inhibitors
CN119626346B (zh) * 2025-02-14 2025-05-06 四川省肿瘤医院 一种医学基因测序数据的模式识别方法及设备

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020357A (en) * 1996-12-23 2000-02-01 Dupont Pharmaceuticals Company Nitrogen containing heteroaromatics as factor Xa inhibitors
ZA985247B (en) * 1997-06-19 1999-12-17 Du Pont Merck Pharma Guanidine mimics as factor Xa inhibitors.
US6339099B1 (en) * 1997-06-20 2002-01-15 Dupont Pharmaceuticals Company Guanidine mimics as factor Xa inhibitors

Also Published As

Publication number Publication date
RU2003111464A (ru) 2004-10-27
IL155043A0 (en) 2003-10-31
NO20031308D0 (no) 2003-03-21
US6667332B2 (en) 2003-12-23
CA2424576A1 (en) 2002-03-28
US20020061917A1 (en) 2002-05-23
WO2002024690A8 (en) 2002-08-08
IS6754A (is) 2003-03-21
ZA200302971B (en) 2005-05-09
HUP0500133A2 (hu) 2005-04-28
SK4892003A3 (en) 2004-04-06
TW593314B (en) 2004-06-21
BG107813A (bg) 2004-01-30
HRP20030316A2 (en) 2005-02-28
WO2002024690A3 (en) 2003-09-25
EP1366045A2 (en) 2003-12-03
CN1610679A (zh) 2005-04-27
PL366027A1 (en) 2005-01-24
NO20031308L (no) 2003-05-07
KR20040043089A (ko) 2004-05-22
JP2004529853A (ja) 2004-09-30
AU2001292612A1 (en) 2002-04-02
US6747158B2 (en) 2004-06-08
US20030212117A1 (en) 2003-11-13
MXPA03002493A (es) 2004-09-10
WO2002024690A2 (en) 2002-03-28
CZ2003835A3 (cs) 2003-12-17
BR0114102A (pt) 2005-04-19
US20040198787A1 (en) 2004-10-07

Similar Documents

Publication Publication Date Title
CY2015028I1 (el) Ενας αναστολεας ν-ακυλοσφιγγοσινο γλυκοζυλοτρανσφερασης
NO20003808D0 (no) Substituerte oksoazaheterosyklylfaktor Xa inhibitorer
PT1224195E (pt) C-aril-glicosidos inibidores de tgls2
CY2007029I2 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
DK1619192T3 (da) Arylkondeserede azapolycykliske forbindelser
FI20000869A0 (fi) Menetelmä kiinnirullaimen toimintavarmuuden parantamiseksi
AR027983A1 (es) Novedosos compuestos
DK1272488T3 (da) Tri-aryl-substitueret ethan-PDE4-inhibitorer
ID29755A (id) Senyawa-senyawa organosilikon
EE200300116A (et) Efektiivne meetod faktori Xa inhibiitori valmistamiseks
PT1299356E (pt) Novos compostos
AR028220A1 (es) Novedosos compuestos
ATE372338T1 (de) Deshalogenverbindungen
NO20030303L (no) Kalsilytiske forbindelser
EP1463521A4 (en) INHIBITOR OF GP41
NO20031837L (no) Kalsilytiske forbindelser
NO20023508D0 (no) Kalsilyttiske forbindelser
TR200100070A3 (tr) Bilesim
DE60206376D1 (de) Faktor xa inhibitor
EE200200447A (et) Meetod tubaka täitevõime parandamiseks
DK1130214T3 (da) Korrosionsinhibitorer
DE60132468D1 (de) Alen-lanosterol zyklase inhibitoren
AR028075A1 (es) Inhibidores de la peptido-desformilasa
DE60114796D1 (de) Analgetisch wirksame benzosuberonylpiperidin-verbindungen
EE200200448A (et) Meetod tubaka täitevõime parandamiseks